Leading Healthy Eating and Activity Promotion Program
University of Alabama at Birmingham · with National Cancer Institute (NCI) · NCT06868524
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–89 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- October 30, 2025
- Record last updated
- May 19, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of the LEAP project is to improve the health and well-being of cancer survivors and their co-survivors living in persistent poverty areas by providing healthy behavior change support. This will be done by engaging the community in adapting beneficial approaches for promoting healthy diet and regular physical activity into a program for cancer survivors and co-survivors that is appropriate for the persistent poverty context and social determinants of health.
Being studied: LEAP Program
Conditions: Cancer Survivor; Cancer; Oncology
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Between the ages of 18 and 89
- English speaking
- Resident of Birmingham area or surrounding community
- History of any type of cancer or the friend or family with of a cancer survivor
Exclusion Criteria
- Serious difficulty hearing
- History of dementia or organic brain syndrome
- On primary treatment for cancer
- No other other medical, psychological, or social characteristic that would interfere with participation in evaluation
Recruiting US locations
University of Alabama at Birmingham
Birmingham, AL 35243
Site contact: Sydney McGlawn · 205-934-8821 · sburdette@uabmc.edu
Study contacts (from the official record)
- Sydney McGlawn · 205-934-8821 · sburdette@uabmc.edu
- Marie-Therese Cooper · 205-934-6897 · marietheresejcooper@uabmc.edu
Similar studies in Alabama
All nutrition & metabolism studies in Alabama →- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Hoffmann-La Roche
- Location
- Birmingham, AL + 121 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Birmingham, AL + 112 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Akero Therapeutics, Inc
- Location
- Birmingham, AL + 131 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
Pfizer
- Location
- Birmingham, AL + 4 other US sites
- Eligibility basics
- Ages 18+